# US 2023/0265490 A1 · Compositions and methods for multiplex detection of mirna and other polynucleotides

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2023/0265490 A1
- Document ID: US20230265490A1
- Status: Published application
- Kind: A1
- Application number: 18/186,015
- Filed: 2023-03-17
- Published: 2023-08-24
- Earliest claimed: 2021-08-20
- Assignees: Kasa Bio, L.L.C.
- Applicants: Kasa Bio, L.L.C.
- Inventors: Kiran Madanahally Divakar; Shashi Bala
- Web page: https://patentgrep.com/patent/US20230265490A1

## CPC

- C12Q 1/6818: involving interaction of two or more labels, e.g. resonant energy transfer
- C12Q 1/6851: Quantitative amplification
- C12Q 2600/16: Primer sets for multiplex assays
- C12Q 2600/178: miRNA, siRNA or ncRNA
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES

## Abstract

Compositions and methods for quantitative detection of target nucleic acids, such as miRNAs are disclosed. The methods are especially advantageous for single-color multiplex detection of two or more targets simultaneously (e.g., in the same reaction). The methods can involve optional reverse transcription followed by amplification performed with universal primers, fluorophore-labeled detection probes, and quencher oligonucleotides for quenching fluorescence of any detection probe not bound to a target molecule. The methods employ differential stability of detection probe-quencher oligonucleotide complexes, and by extension, differential fluorescence at various temperatures to distinguish between different target molecules.

## Claims

### Claim 1

A method for detection of two or more distinct target polynucleotides in a sample the method comprising performing one or more amplification cycles on the sample using a polymerase and universal or target-specific forward and reverse primers to generate amplified products corresponding to the target polynucleotides, and detecting and/or quantifying each amplified product using a plurality of distinct unbound detection probes and a plurality of corresponding quencher oligonucleotides that can hybridize thereto.

### Claim 2 (depends on 1)

The method of claim 1, wherein the quencher oligonucleotide and probe are not linked.

### Claim 3 (depends on 1)

The method of claim 1, wherein the primers comprise or consist of labeled, target-specific forward and/or reverse primers and wherein the probes are the labelled primers, and, optionally wherein the labelled primers and quencher oligonucleotides are not linked.

### Claim 4 (depends on 1)

The method of claim 1, wherein the probes and corresponding quencher oligonucleotides are linked.

### Claim 5 (depends on 1)

The method of claim 1, wherein each detection probe in the plurality of detection probes comprises an identical fluorophore, and a target-specific sequence that is complementary to and hybridizes to a target amplified product.

### Claim 6 (depends on 5)

The method of claim 5, wherein each detection probe in the plurality of detection probes comprises a tag different in sequence and/or size from that of other distinct probes in the plurality of detection probes.

### Claim 7 (depends on 6)

The method of claim 6, wherein the plurality of quencher oligonucleotides comprises an identical fluorescence quencher and an identical tag-binding sequence that is partially or fully complementary to the tags of the detection probes.

### Claim 8 (depends on 6)

The method of claim 6, wherein for each distinct detection probe, the plurality of quencher oligonucleotides comprises a quencher oligonucleotide comprising a sequence that is fully complementary to part or all of the sequence of the distinct detection probe, wherein each quencher oligonucleotide in the plurality of quencher oligonucleotides comprises an identical fluorescence quencher and differs from other quencher oligonucleotides in sequence.

### Claim 9 (depends on 7)

The method of claim 7, wherein the quencher oligonucleotides are capable of hybridizing to each distinct detection probe to form a plurality of unique detection probe-quencher oligonucleotide complexes, wherein each detection probe-quencher oligonucleotide complex exhibits a unique melting temperature.

### Claim 10 (depends on 9)

The method of claim 9, wherein formation of the detection probe-quencher oligonucleotide complex results in quenching of fluorescence from the fluorophore by the fluorescence quencher, wherein fluorescence is unquenched at a temperature above the unique melting temperature for each detection probe-quencher oligonucleotide complex.

### Claim 11 (depends on 10)

The method of claim 10, wherein fluorescence is measured at or below each unique melting temperature after one or more amplification cycles, optionally after each amplification cycle, and/or at the beginning and the end of the amplification reaction.

### Claim 12 (depends on 11)

The method of claim 11, wherein the amplified products corresponding to the two or more target polynucleotides are distinguished and/or quantified by the amount of fluorescence arising from unbound probe and quencher oligonucleotide complex dissociation measured at each unique

### Claim 13 (depends on 1)

The method of claim 1, wherein the plurality of detection probes comprises two or more groups of detection probes, wherein each group of detection probes comprises an identical fluorophore, wherein each distinct detection probe in a group comprises a tag different in sequence and/or size from that of other probes in the group, and a target-specific sequence that is complementary to and hybridizes to a distinct target amplified product.

### Claim 14 (depends on 13)

The method of claim 13, wherein each group of detection probes comprises 3 or 4 distinct detection probes.

### Claim 15 (depends on 13)

The method of claim 13, wherein for each group of detection probes the plurality of quencher oligonucleotides comprises an identical fluorescence quencher and an identical tag-binding sequence that is partially or fully complementary to the tags of the detection probes in the group or the plurality of quencher oligonucleotides comprises specific sequences that is fully complementary to the detection probes in the group.

### Claim 16 (depends on 13)

The method of claim 13, wherein for each distinct detection probe, the plurality of quencher oligonucleotides comprises a quencher oligonucleotide comprising a sequence that is fully complementary to part or all of the sequence of the distinct detection probe, and wherein for each group of detection probes, each quencher oligonucleotide in the plurality of quencher oligonucleotides comprises an identical fluorescence quencher.

### Claim 17 (depends on 15)

The method of claim 15, wherein the quencher oligonucleotides are capable of hybridizing to each distinct detection probe to form a plurality of unique detection probe-quencher oligonucleotide complexes, wherein each detection probe-quencher oligonucleotide complex exhibits a unique melting temperature.

### Claim 18 (depends on 17)

The method of claim 17, wherein formation of the detection probe-quencher oligonucleotide complex results in quenching of fluorescence from the fluorophore by the fluorescence quencher, wherein fluorescence is unquenched at a temperature above the unique melting temperature for each detection probe-quencher oligonucleotide complex.

### Claim 19 (depends on 18)

The method of claim 18, wherein fluorescence is measured at each unique melting temperature after one or more amplification cycles, optionally after each amplification cycle, and/or at the beginning and the end of the amplification reaction.

### Claim 20 (depends on 19)

The method of claim 19, wherein the amplified products corresponding to the two or more target polynucleotides are distinguished and/or quantified by the amount of fluorescence measured at each temperature.

### Claim 21 (depends on 1)

The method of claim 1, wherein the amplification comprises isothermal amplification, or PCR, optionally wherein the PCR is quantitative PCR (qPCR) or digital PCR (dPCR).

### Claim 22 (depends on 1)

The method of claim 1, wherein the fluorophore(s) is/are selected from FAM, HEX, VIC, JOE, TET, SUN, TAMRA, QUASAR-670, CFR560 (CAL Fluor Red), CFR610, Texas Red and/or the fluorescence quencher is selected from BHQ1, BHQ2, and BHQ3.

### Claim 23 (depends on 1)

The method of claim 1, wherein the target polynucleotide comprises DNA or RNA.

### Claim 24 (depends on 23)

The method of claim 23, wherein the target polynucleotide comprises RNA and the amplification is preceded by reverse transcription of the RNA.

### Claim 25 (depends on 24)

The method of claim 24, wherein the RNA is selected from small nucleolar RNA, messenger RNA (mRNA), small interfering RNA (siRNA), microRNA (miRNA), or antisense RNA.

### Claim 26 (depends on 25)

The method of claim 25, wherein the RNA is miRNA, wherein reverse transcription of the miRNA comprises (a) bringing a sample comprising the miRNA into contact with a single-stranded RT primer and optionally a blocker oligonucleotide under conditions suitable for the RT primer to hybridize to the target miRNA,
wherein the RT primer comprises in the 5′ to 3′ direction, (i) a tag collectively comprising a universal reverse primer sequence and a binding site for the blocker oligonucleotide, and (ii) a sequence complementary to the 3′-end of the target miRNA; and (b) performing reverse transcription to obtain cDNA.

### Claim 27

A method for detection of target miRNA, the method comprising:
(a) bringing into contact a sample comprising RNA with a single-stranded reverse transcription (RT) primer and optionally a blocker oligonucleotide under conditions suitable for the RT primer to hybridize to a target miRNA,
wherein the RT primer comprises in the 5′ to 3′ direction, (i) a tag collectively comprising a universal reverse primer sequence and a binding site for the blocker oligonucleotide, and (ii) a sequence complementary to the 3′-end of the target miRNA;
(b) performing reverse transcription to obtain cDNA; and
(c) amplifying the cDNA by PCR using a first PCR primer and the RT primer to generate double-stranded DNA template, wherein the first PCR primer comprises in the 5′ to 3′ direction, a universal forward primer sequence, a tag, and a sequence corresponding to the 5′-end of the target miRNA; and
(d) amplifying the DNA template from step (c) to generate an amplified product corresponding to the target miRNA, and detecting and/or quantifying the amplified product.

### Claim 28 (depends on 27)

The method of claim 27, wherein the blocker oligonucleotide hybridizes to the RT primer at the binding site for the blocker oligonucleotide, and/or adjacent to the 3′-end of the target miRNA when it is hybridized to the RT primer.

### Claim 29 (depends on 28)

The method of claim 28, wherein the blocker oligonucleotide comprises about 12-16 nucleotides.

### Claim 30 (depends on 29)

The method of claim 29, wherein the amplifying in (d) comprises performing the real-time qPCR in the presence of a detection probe and a quencher oligonucleotide, wherein the detection probe comprises a fluorophore, a first region comprising a sequence complementary to the tag of the first PCR primer, and a second region comprising a sequence that is complementary to the amplified product; and
wherein the quencher oligonucleotide comprises a fluorescence quencher and a sequence that is complementary to the first region of the detection probe.
